{
  "story_id": "65e48da3813aa7823522d2506d971b1b",
  "desk": "drm3",
  "revision": 1,
  "published_at": "2026-11-18T10:49:50.000Z",
  "content_hash": "ac00a4581545e38fb8aa6d9b06b37f7aa76e5e73c8780dad6759534ca36e7fbb",
  "hash_basis": "sha256 over `headline\\ndek\\nprose`, plus `\\n` + the canonical citations JSON when any source is placed, plus `\\n#blog` for blogs",
  "basis": {
    "headline": "Alphabet's Isomorphic Labs secures $5B funding for AI drug discovery",
    "dek": "Isomorphic Labs closes $5B investment round led by Greenoaks and Sequoia Capital.",
    "prose": "Isomorphic Labs announced it closed a $5 billion investment round led by Greenoaks and Sequoia Capital. [^1]\n\nIsomorphic Labs raised $5 billion in an oversubscribed Series C financing round. [^2] Isomorphic Labs CEO Demis Hassabis stated the funding will enable progress toward clinical trials for therapeutic programs. [^3] Isomorphic Labs operates the IsoDDE AI platform which accelerates drug discovery workflows including protein binding pocket identification. [^4]\n\nParent company Alphabet participated in the funding round via its GV and CapitalG startup funds with a significant investment. [^5] Capital will be used to scale the IsoDDE AI drug design engine, expand therapeutic pipelines, and build clinical development infrastructure. [^6] Sequoia Capital and Greenoaks co-led the Series C round, with participation from Andreessen Horowitz, Alphabet, and existing investors. [^7]\n\nThis $5 billion raise is the largest ever venture capital round for a life sciences company globally. [^8]",
    "cited": "[{\"statement\":\"Isomorphic Labs announced it closed a $5 billion investment round led by Greenoaks and Sequoia Capital.\",\"source\":\"SiliconANGLE\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-17T23:51:11.000Z\",\"publisher_count\":1,\"sources\":[\"SiliconANGLE\"],\"url\":\"https://siliconangle.com/2026/11/17/alphabets-isomorphic-labs-raises-5b-to-accelerate-drug-discovery-with-ai/\"},{\"statement\":\"Isomorphic Labs raised $5 billion in an oversubscribed Series C financing round.\",\"source\":\"Pharmaceutical Technology\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-18T10:49:50.000Z\",\"publisher_count\":1,\"sources\":[\"Pharmaceutical Technology\"],\"url\":\"https://www.pharmaceutical-technology.com/news/isomorphic-labs-5bn-advance-drug-pipeline/\"},{\"statement\":\"Isomorphic Labs CEO Demis Hassabis stated the funding will enable progress toward clinical trials for therapeutic programs.\",\"source\":\"SiliconANGLE\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-17T23:51:11.000Z\",\"publisher_count\":1,\"sources\":[\"SiliconANGLE\"],\"url\":\"https://siliconangle.com/2026/11/17/alphabets-isomorphic-labs-raises-5b-to-accelerate-drug-discovery-with-ai/\"},{\"statement\":\"Isomorphic Labs operates the IsoDDE AI platform which accelerates drug discovery workflows including protein binding pocket identification.\",\"source\":\"SiliconANGLE\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-17T23:51:11.000Z\",\"publisher_count\":1,\"sources\":[\"SiliconANGLE\"],\"url\":\"https://siliconangle.com/2026/11/17/alphabets-isomorphic-labs-raises-5b-to-accelerate-drug-discovery-with-ai/\"},{\"statement\":\"Parent company Alphabet participated in the funding round via its GV and CapitalG startup funds with a significant investment.\",\"source\":\"SiliconANGLE\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-17T23:51:11.000Z\",\"publisher_count\":1,\"sources\":[\"SiliconANGLE\"],\"url\":\"https://siliconangle.com/2026/11/17/alphabets-isomorphic-labs-raises-5b-to-accelerate-drug-discovery-with-ai/\"},{\"statement\":\"Capital will be used to scale the IsoDDE AI drug design engine, expand therapeutic pipelines, and build clinical development infrastructure.\",\"source\":\"Pharmaceutical Technology\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-18T10:49:50.000Z\",\"publisher_count\":1,\"sources\":[\"Pharmaceutical Technology\"],\"url\":\"https://www.pharmaceutical-technology.com/news/isomorphic-labs-5bn-advance-drug-pipeline/\"},{\"statement\":\"Sequoia Capital and Greenoaks co-led the Series C round, with participation from Andreessen Horowitz, Alphabet, and existing investors.\",\"source\":\"Pharmaceutical Technology\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-18T10:49:50.000Z\",\"publisher_count\":1,\"sources\":[\"Pharmaceutical Technology\"],\"url\":\"https://www.pharmaceutical-technology.com/news/isomorphic-labs-5bn-advance-drug-pipeline/\"},{\"statement\":\"This $5 billion raise is the largest ever venture capital round for a life sciences company globally.\",\"source\":\"Pharmaceutical Technology\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-18T10:49:50.000Z\",\"publisher_count\":1,\"sources\":[\"Pharmaceutical Technology\"],\"url\":\"https://www.pharmaceutical-technology.com/news/isomorphic-labs-5bn-advance-drug-pipeline/\"}]",
    "kind": "news"
  },
  "receipt_verify": "Ed25519 over the dot-joined string `slice_hash.cursor_from.cursor_to.view.view_version.row_count`; public_key and sig are base64url of the raw 32-byte key / 64-byte signature",
  "receipt": {
    "slice_hash": "1f63e02d8fabc9e41f5002beeeb1b89166508b35e4ee620dbfaad4f7cfb1c431",
    "cursor_from": "ingest:raw_newsroomfloor.stories:1f63e02d8fabc9e4",
    "cursor_to": "ingest:raw_newsroomfloor.stories:1f63e02d8fabc9e4",
    "view": "ingest:raw_newsroomfloor.stories",
    "view_version": "1",
    "row_count": 1,
    "hash_basis": "sha256 over the JSON array of {insertId, json} rows as received (normalized wire shape), computed before the BigQuery forward",
    "credits": 0.01,
    "price_per_100_rows_written": 1,
    "sig": "QdF6I0yqJdrIPkWcd9V-WmjYnwIKYJrDyZGz4IJHWWAqFrf41tNzAVsytacnyhtAi_qJcDgCcioT1BcOQuXGBA",
    "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE",
    "signer_path": "lakehouse/data-extract/v1",
    "alg": "Ed25519",
    "signed": true
  },
  "receipt_note": "the ingest door's signed receipt for this revision, verbatim as the door returned it",
  "generation_chain": {
    "wire": {
      "stream": "fountain_news",
      "story_id": "38fe548549ef05a51df963b00bcae9ca",
      "thread_id": "a996a6d3e857fa09dab4607f385e26a6",
      "thread_label": "IsoDDE",
      "novelty": "UPDATE",
      "content_hash": "a13a353db3c04e392e5a4ecaeb67557cf3dcffcce73a1b63327434646d8b8de7",
      "compose": 3,
      "last_published_at": "2026-11-18T10:49:50.000Z",
      "read_receipt": {
        "slice_hash": "5d81fe2ace6a617cd4ba7058f2bbb110cc28e795819e6957811ca3f24e095fba",
        "cursor_from": "eyJ0cyI6IjIwMjYtMTEtMThUMTA6MTc6NTIuMDAwWiIsImlkIjoiZmQxMWI2YjgyMGMyOWM2ODY0OWU3NWZkZTBhYjU2N2UiLCJ2IjoiMSJ9",
        "cursor_to": "eyJ0cyI6IjIwMjYtMTEtMThUMTM6MTA6MjQuMDAwMDAwWiIsImlkIjoiYzRlYzM0NjUxYzBmMjZjZjkyMTI0YWExMWIyZTZhNzIiLCJ2IjoiMSJ9",
        "view": "v_fountain_news",
        "view_version": "1",
        "row_count": 100,
        "window_days": 3,
        "bytes_scanned": 3577351,
        "credits": 8,
        "price_per_100_rows": 8,
        "sig": "QZth9KulSt_LWFWw1v8rUYmiywwf-3DBLhqaJJqv2QD13YMTy_Mhalhi6EU2TeWxEdQ2dMHqu73j-4JAjMpdBg",
        "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE",
        "signer_path": "lakehouse/data-extract/v1",
        "alg": "Ed25519",
        "signed": true
      },
      "landing": "air"
    },
    "written_at": "2026-11-19T21:07:27.497Z"
  },
  "cited_facts": [
    {
      "n": 1,
      "statement": "Isomorphic Labs announced it closed a $5 billion investment round led by Greenoaks and Sequoia Capital.",
      "source": "SiliconANGLE",
      "instrument": "News",
      "claim_key": null,
      "url": "https://siliconangle.com/2026/11/17/alphabets-isomorphic-labs-raises-5b-to-accelerate-drug-discovery-with-ai/",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 2,
      "statement": "Isomorphic Labs raised $5 billion in an oversubscribed Series C financing round.",
      "source": "Pharmaceutical Technology",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.pharmaceutical-technology.com/news/isomorphic-labs-5bn-advance-drug-pipeline/",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 3,
      "statement": "Isomorphic Labs CEO Demis Hassabis stated the funding will enable progress toward clinical trials for therapeutic programs.",
      "source": "SiliconANGLE",
      "instrument": "News",
      "claim_key": null,
      "url": "https://siliconangle.com/2026/11/17/alphabets-isomorphic-labs-raises-5b-to-accelerate-drug-discovery-with-ai/",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 4,
      "statement": "Isomorphic Labs operates the IsoDDE AI platform which accelerates drug discovery workflows including protein binding pocket identification.",
      "source": "SiliconANGLE",
      "instrument": "News",
      "claim_key": null,
      "url": "https://siliconangle.com/2026/11/17/alphabets-isomorphic-labs-raises-5b-to-accelerate-drug-discovery-with-ai/",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 5,
      "statement": "Parent company Alphabet participated in the funding round via its GV and CapitalG startup funds with a significant investment.",
      "source": "SiliconANGLE",
      "instrument": "News",
      "claim_key": null,
      "url": "https://siliconangle.com/2026/11/17/alphabets-isomorphic-labs-raises-5b-to-accelerate-drug-discovery-with-ai/",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 6,
      "statement": "Capital will be used to scale the IsoDDE AI drug design engine, expand therapeutic pipelines, and build clinical development infrastructure.",
      "source": "Pharmaceutical Technology",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.pharmaceutical-technology.com/news/isomorphic-labs-5bn-advance-drug-pipeline/",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 7,
      "statement": "Sequoia Capital and Greenoaks co-led the Series C round, with participation from Andreessen Horowitz, Alphabet, and existing investors.",
      "source": "Pharmaceutical Technology",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.pharmaceutical-technology.com/news/isomorphic-labs-5bn-advance-drug-pipeline/",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 8,
      "statement": "This $5 billion raise is the largest ever venture capital round for a life sciences company globally.",
      "source": "Pharmaceutical Technology",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.pharmaceutical-technology.com/news/isomorphic-labs-5bn-advance-drug-pipeline/",
      "occurred_at": null,
      "published_at": null
    }
  ],
  "note": "A signature proves who filed this and that it has not changed since. It never makes a claim true. The dates on cited_facts (occurred_at, published_at) are the forge's, joined at read time; they are not part of the signed basis above."
}